Language

English

Publication Date

2-9-2023

Journal

Genes

DOI

10.3390/genes14020447

PMID

36833373

PMCID

PMC9956865

PubMedCentral® Posted Date

2-9-2023

PubMedCentral® Full Text Version

Post-print

Abstract

Inherited retinal diseases (IRDs) are a diverse set of visual disorders that collectively represent a major cause of early-onset blindness. With the reduction in sequencing costs in recent years, whole-genome sequencing (WGS) is being used more frequently, particularly when targeted gene panels and whole-exome sequencing (WES) fail to detect pathogenic mutations in patients. In this study, we performed mutation screens using WGS for a cohort of 311 IRD patients whose mutations were undetermined. A total of nine putative pathogenic mutations in six IRD patients were identified, including six novel mutations. Among them, four were deep intronic mutations that affected mRNA splicing, while the other five affected protein-coding sequences. Our results suggested that the rate of resolution of unsolved cases via targeted gene panels and WES can be further enhanced with WGS; however, the overall improvement may be limited.

Keywords

Humans, Exome, Retinal Diseases, Whole Genome Sequencing, Mutation, Exome Sequencing, inherited retinal diseases, whole-genome sequencing (WGS), targeted gene panels, whole-exome sequencing, deep intronic mutations

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.